ロード中...
Molecular ablation of tumor blood vessels inhibits therapeutic effects of radiation and bevacizumab
BACKGROUND: Glioblastoma (GBM) is an aggressive and highly vascular tumor with median survival below 2 years. Despite advances in surgery, radiotherapy, and chemotherapy, survival has improved modestly. To combat glioma vascular proliferation, anti-angiogenic agents targeting vascular endothelial gr...
保存先:
| 出版年: | Neuro Oncol |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6140787/ https://ncbi.nlm.nih.gov/pubmed/29660022 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy055 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|